198 related articles for article (PubMed ID: 32500251)
1. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE.
Hu B; Zhong BY; Zhang L; Dai C; Li W; Shen J; Huang P; Zhang S; Li Z; Ni CF
Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1460-1467. PubMed ID: 32500251
[TBL] [Abstract][Full Text] [Related]
2. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of 1-year tumor response of hepatocellular carcinoma with lipiodol deposition pattern through post-embolization cone-beam computed tomography during conventional transarterial chemoembolization.
Tsai YC; Shih JH; Hwang HE; Chiu NC; Lee RC; Tseng HS; Liu CA
Eur Radiol; 2021 Oct; 31(10):7464-7475. PubMed ID: 33765160
[TBL] [Abstract][Full Text] [Related]
4. Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.
Langenbach MC; Vogl TJ; Said G; Scholtz JE; Hammerstingl R; Gruber-Rouh T
Cancer Biother Radiopharm; 2024 Apr; 39(3):196-202. PubMed ID: 33481646
[No Abstract] [Full Text] [Related]
5. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.
Adhoute X; Pénaranda G; Raoul JL; Pietri O; Bronowicki JP; Castellani P; Perrier H; Monnet O; Bayle O; Oules V; Pol B; Beaurain P; Muller C; Cassagneau P; Bourlière M
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1414-1423. PubMed ID: 31045613
[TBL] [Abstract][Full Text] [Related]
7. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.
Dioguardi Burgio M; Sartoris R; Libotean C; Zappa M; Sibert A; Vilgrain V; Ronot M
Cancer Imaging; 2019 Nov; 19(1):75. PubMed ID: 31730491
[TBL] [Abstract][Full Text] [Related]
8. The value of paradoxical uptake of hepatocellular carcinoma on the hepatobiliary phase of gadoxetic acid-enhanced liver magnetic resonance imaging for the prediction of lipiodol uptake after transcatheter arterial chemoembolization.
Kim JW; Lee CH; Park YS; Seo TS; Song MG; Kim JH; Kim KA; Park CM
Eur J Radiol; 2017 Apr; 89():169-176. PubMed ID: 28267535
[TBL] [Abstract][Full Text] [Related]
9. Lipiodol as an intra-procedural imaging biomarker for liver tumor response to transarterial chemoembolization: Post-hoc analysis of a prospective clinical trial.
Letzen BS; Malpani R; Miszczuk M; de Ruiter QMB; Petty CW; Rexha I; Nezami N; Laage-Gaupp F; Lin M; Schlachter TR; Chapiro J
Clin Imaging; 2021 Oct; 78():194-200. PubMed ID: 34022765
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of Vascular Lake Phenomenon as a Predictor of Improved Tumor Response in HCC Patients That Underwent DEB-TACE.
Cavalcante RN; Nasser F; Motta-Leal-Filho JM; Affonso BB; Galastri FL; De Fina B; Garcia RG; Wolosker N
Cardiovasc Intervent Radiol; 2017 Jul; 40(7):1044-1051. PubMed ID: 28500458
[TBL] [Abstract][Full Text] [Related]
11. Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma.
Kattipatanapong T; Nishiofuku H; Tanaka T; Sato T; Masada T; Tatsumoto S; Matsumoto T; Kichikawa K
Cardiovasc Intervent Radiol; 2020 Mar; 43(3):423-433. PubMed ID: 31720806
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT.
Wang Z; Lin M; Lesage D; Chen R; Chapiro J; Gu T; Tacher V; Duran R; Geschwind JF
Acad Radiol; 2014 Mar; 21(3):393-9. PubMed ID: 24507426
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of transcatheter arterial chemoembolization with embospheres in treatment of hepatocellular carcinoma.
Hao MZ; Lin HL; Chen QZ; Hu YB; Chen JB; Zheng JX; Zhou D; Zhang H
J Dig Dis; 2017 Jan; 18(1):31-39. PubMed ID: 27987344
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
15. Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
Chen S; Peng Z; Zhang Y; Chen M; Li J; Guo R; Li J; Li B; Mei J; Feng S; Kuang M
Radiology; 2021 Mar; 298(3):680-692. PubMed ID: 33464183
[TBL] [Abstract][Full Text] [Related]
16. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
[TBL] [Abstract][Full Text] [Related]
17. Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure.
Irie T; Kuramochi M; Takahashi N
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):706-13. PubMed ID: 22996589
[TBL] [Abstract][Full Text] [Related]
18. Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas?
Kang HJ; Kim YI; Kim HC; Jae HJ; Hur S; Chung JW
Korean J Radiol; 2015; 16(5):1068-78. PubMed ID: 26357501
[TBL] [Abstract][Full Text] [Related]
19. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
[TBL] [Abstract][Full Text] [Related]
20. Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)?
Somma F; D'Angelo R; Serra N; Gatta G; Grassi R; Fiore F
PLoS One; 2015; 10(6):e0129573. PubMed ID: 26110810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
